However, importantly, it was associated with an intense downregulation of expression of PTX3 mRNA, which codifies PTX3 synthesis, suggesting a significant change/modulation at a posttranscriptional rather than posttranslational level that has not been previously reported in patients with severe genetically defined dyslipidemia and associated CAD. This evidence concerns the gene PTX3 and coronary artery disorder.